According to the PR Newswire, attorneys representing consumers and third-party payors today announced a proposed $41.5 million settlement of a class action lawsuit with drug manufacturers Merck & Co.and Schering-Plough Corporation to settle allegations the companies suppressed critical information about the efficacy and safety of prescription drugs Vytorin and Zetia. Merck and Schering-Plough previously settled similar claims with 35 states and the District of Columbia for $5.4 million.
Hagens Berman Sobol Shapiro (HBSS), counsel for a nationwide class of third-party payors, brought the class action suit against manufacturers along with consumers in January 2008. Thomas M. Sobol, lead attorney on the case, hailed the agreement as an excellent result for plaintiffs.
"I am very pleased that we reached a comprehensive settlement that serves our clients' interest so well," Sobol said. "This settlement also reflects the vital role private litigation plays in holding pharmaceutical companies accountable when the FDA cannot."
If you need to find a LA-based class action law firm, Ringler Kearney Alvarez can assist you. Contact them to set up a consultation.
Hagens Berman Sobol Shapiro (HBSS), counsel for a nationwide class of third-party payors, brought the class action suit against manufacturers along with consumers in January 2008. Thomas M. Sobol, lead attorney on the case, hailed the agreement as an excellent result for plaintiffs.
"I am very pleased that we reached a comprehensive settlement that serves our clients' interest so well," Sobol said. "This settlement also reflects the vital role private litigation plays in holding pharmaceutical companies accountable when the FDA cannot."
If you need to find a LA-based class action law firm, Ringler Kearney Alvarez can assist you. Contact them to set up a consultation.